28 September

HAI Holds Workshops on EU Medicines Policy & Access to Medicines in Eastern Europe

9 June

HAI urges MEPs to support key amendments to TTIP resolution

4 February

The EU-US Trade Deal Could Leave Europeans Sick

9 December

More work needed on new EMA conflicts of interest policy

15 October

EMA policy on clinical data publication a step ahead, but falls short of true potential

18 September

Abysmal decisions: Why the EC’s medicinal units shouldn’t be moved to DG Industry

16 September

Democracy violation: European Commission rejects citizens’ initiative to stop TTIP and CETA

15 July

School's IN for summer: HAI staff and interns inspired by Utrecht University's course on pharmaceutical policy analysis

23 June

Setting precedents: EMA must get clinical trial data policy right to truly act in public interest

11 June

HAI Europe calls on EMA's Management Board to stand for data transparency

10 April

Tamiflu review shows desperate need for full clinical trials data transparency

24 February

A new (and improved) model to regulate pharmaceutical promotion

31 January

Bayer CEO's callous comments highlight failure of current biomedical innovation model

25 November

When politicians go to the movies

12 July

DG Trade State of Play reveals EU's ambitions for IP protection in FTAs

25 February

European drug regulator challenged over revolving door case involving former Director

1 February

Corporate funding linked to EU patient & consumer groups policy

20 December

EMA reviews transparency criteria

1 December

HAI research on financial disclosure featured in article: European politicians' call for greater transparency

22 October

HAI Europe Statement: EMA talks the ‘conflicts of interest’ talk, but will it walk the walk?

23 September

Dutch Minister of Health supports HAI E's financial transparency recommendations to EMA

2 September

Report exposes how Big Pharma has hijacked EU-India trade deal

30 August

In perspective: EMA comments on HAI Europe's survey of financial disclosure

25 August

Impact of HAI Europe survey results: Two weeks on

11 August

HAI Europe survey reveals new data on financial transparency of patient and consumer organisations

28 June

HAI Europe recommendations for improved conflict of interest declarations at EMA

23 June

ISDB & MiEF criticize EMA over conflict of interest procedures

14 June

Review of conflict of interest policies in three European medicines regulation agencies

11 May

EU Ombudsman: Transparency rules apply to all documents held by EMA

28 April

European Medicines Agency faces tough questions about patient groups' transparency